510(k) Report

FDA applicant

Micrus Endovascular Corporation

San Jose, CA23 decisions2005–20112 recalls

FDA records 23 decisions for Micrus Endovascular Corporation (San Jose, CA) from 2005 to 2011: 23 510(k) clearances. Most are in product codes HCG (Device, Neurovascular Embolization) and DQO (Catheter, Intravascular, Diagnostic). Its devices cite 45 predicates, 21 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Micrus Endovascular Corporation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2011

2007: 62008: 52009: 52010: 12011: 1
2007high 6 (2007) · low 0 (2012)2026

2026 so far, outlined.

Recalls per year

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Micrus Endovascular Corporation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Micrus Endovascular Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Micrus”

FDA records each applicant name separately; these may or may not be the same firm.